Elekta MONACO RTP Sytem, radiation treatment planning software system - Product Usage: The Monaco...
FDA Device Recall #Z-1825-2020 — Class II — April 16, 2020
Recall Summary
| Recall Number | Z-1825-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 16, 2020 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Elekta Inc |
| Location | Saint Charles, MO |
| Product Type | Devices |
| Quantity | 96 devices |
Product Description
Elekta MONACO RTP Sytem, radiation treatment planning software system - Product Usage: The Monaco system is used to make treatment plans for patients with prescriptions for external beam radiation therapy. The
Reason for Recall
The Monaco RTP Radiation Treatment Planning System may change the shape and volume of the contour potentially resulting in the device delivering an inaccurate dose.
Distribution Pattern
Worldwide distribution - US Nationwide Distribution in the states of IA, NJ, NY, PA, TX, WI and the countries of Australia, Canada, China, Denmark, Germany, Hong Kong, Italy, Netherlands, Sweden, Switzerland, Thailand, Turkey, United Kingdom.
Lot / Code Information
Software Build: 5.40.00 (UDI: (01)00858164002190(10) 5.40.00), 5.40.01 (UDI: 01)00858164002190(10) 5.40.01)
Other Recalls from Elekta Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1233-2023 | Class II | Monaco RTP System. Used to make treatment ... | Feb 28, 2023 |
| Z-2563-2021 | Class II | Elekta Monaco - Product Usage: used to make tre... | Sep 14, 2021 |
| Z-2406-2021 | Class II | Monaco RTP System, Software Builds 5.40.00, 5.4... | Jul 26, 2021 |
| Z-1826-2020 | Class II | Leksell Vantage Stereotactic System. Instrument... | Mar 30, 2020 |
| Z-0670-2020 | Class II | Monaco Radiation Treatment Planning System (RTP... | Nov 22, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.